Published on 31 May 2021 on SmarterAnalyst via Yahoo Finance
BiomX Reports Q1 Earnings; Shares Jump 6%
BiomX Inc. (PHGE) reported a Q1 loss of $0.35 per share as compared to a loss of $0.26 per share reported in the prior year’s quarter. Shares jumped as much as 6% on the news and closed at $6.19 on May 24, up 1.6% from the previous day.
BiomX is a clinical-stage microbiome company that engages in developing bacteriophage-based therapies for the treatment and prevention of diseases stemming from dysbiosis of the microbiome.
R&D expenses for the quarter stood at $5.79 million, up 64% from the prior year’s quarter. The increase was mainly due to a higher number of employees and their related expenses, together with higher expenses related to clinical activities and related trials. (See BiomX stock analysis on TipRanks)